Daniel L. Goodwin’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,523
Closed -$204K 97
2019
Q4
$204K Hold
9,523
0.09% 80
2019
Q3
$220K Buy
+9,523
New +$203K 0.1% 82
2018
Q4
Sell
-9,523
Closed -$221K 95
2018
Q3
$221K Hold
9,523
0.1% 83
2018
Q2
$207K Buy
+9,523
New +$186K 0.1% 85
2016
Q1
Sell
-20,000
Closed -$405K 114
2015
Q4
$405K Buy
+20,000
New +$421K 0.1% 66
2015
Q1
Sell
-15,334
Closed -$466K 142
2014
Q4
$466K Hold
15,334
0.08% 78
2014
Q3
$373K Sell
15,334
-8,000
-34% -$222K 0.08% 75
2014
Q2
$670K Hold
23,334
0.12% 55
2014
Q1
$651K Hold
23,334
0.12% 59
2013
Q4
$610K Hold
23,334
0.12% 62
2013
Q3
$537K Hold
23,334
0.11% 66
2013
Q2
$609K Buy
+23,334
New +$673K 0.12% 60

Other funds holding SBRA

Daniel L. Goodwin's SBRA Position: Q1 2020 in Review

Daniel L. Goodwin sold out of Sabra Healthcare REIT (SBRA) in Q1 2020, closing a stake of 9,523 shares — an estimated $204K sold.

Daniel L. Goodwin first reported a position in SBRA in Q2 2013 and held it in 12 quarters. The position peaked at $670K in Q2 2014. 324 funds tracked by Wall St. Rank hold SBRA as of Q1 2020.

  • Daniel L. Goodwin reported no remaining Sabra Healthcare REIT position as of Q1 2020 after selling out during the quarter.
  • Daniel L. Goodwin sold 9,523 Sabra Healthcare REIT shares in Q1 2020, an estimated $204K.
  • Daniel L. Goodwin first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 12 quarters.
  • Daniel L. Goodwin's Sabra Healthcare REIT position peaked at $670K in Q2 2014.
  • 324 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2020.

Based on Daniel L. Goodwin's 13F filing for Q1 2020, filed 17 Apr 2020.